Compile Data Set for Download or QSAR
maximum 50k data
Found 385 of ph data with Target = 'Vasopressin V1b receptor'
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM174904(US9688678, 1A (+)-3-(2-ethoxy-5-methoxy-phenyl)-1-...)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175064(US9688678, 25 (+)-3-(2-ethoxy-5-methoxy-phenyl)-1-...)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175060(US9688678, 21 (+-)-3-(2,5-dimethoxyphenyl)-1-[(5-m...)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175058(US9688678, 19 (+-)-3-(2-ethoxy-5-methoxy-phenyl)-3...)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175057(US9688678, 18A (+)-3-(2-methoxyphenyl)-1-[(5-metho...)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175056(US9688678, 18 (+-)3-(2-methoxyphenyl)-1-[(5-methox...)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175055(US9688678, 17B (+)-3-(2-ethoxy-5-methoxy-phenyl)-1...)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175054(US9688678, 17 (+-)-3-(2-ethoxy-5-methoxy-phenyl)-1...)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175039(US9688678, 11 (+)-3-(2-ethoxy-5-methoxyphenyl)-1-(...)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175037(US9688678, 9A (+)-3-(2-ethoxy-3-pyridyl)-1-[(5-met...)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175212(US9688678, 34 (3S)-1-[(5-chloro-2-pyridyl)sulfonyl...)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175068(US9688678, 29 (+-)-3-(2-ethoxy-5-methoxy-phenyl)-1...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175211(US9688678, 33 (3S)-3-(2-ethoxy-5-methoxy-phenyl)-3...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175066(US9688678, 27 (+-)-3-(2-ethoxy-3-pyridyl)-1-[(5-me...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175065(US9688678, 26 (+-)-3-(2-methoxyphenyl)-1-[(5-metho...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175032(US9688678, 5 (+-)-3-(2-ethoxy-5-methoxy-phenyl)-1-...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175038(US9688678, 10 (+-)-3-(2-ethoxy-5-methoxy-phenyl)-1...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175034(US9688678, 7 (+-)-3-(2-ethoxy-4-fluoro-phenyl)-1-[...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175035(US9688678, 8 (+-)-3-(2-ethoxyphenyl)-1-[(5-methoxy...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175036(US9688678, 9 (+-)-3-(2-ethoxy-3-pyridyl)-1-[(5-met...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175069(US9688678, 30 (+-)-3-[2-(1,1-difluoroethyl)-3-pyri...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175074(US9688678, 31 (3S)-3-(2-ethoxy-5-methoxy-phenyl)-1...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175059(US9688678, 20 (+-)-3-(2-ethoxy-5-methoxy-phenyl)-3...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM174900(US9688678, 1 (+-)-3-(2-ethoxy-5-methoxy-phenyl)-1-...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175061(US9688678, 22 (+-)-3-(2-methoxy-3-pyridyl)-1-[(5-m...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175062(US9688678, 23 (+)-3-(2-methoxyphenyl)-1-[(5-methox...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175067(US9688678, 28 (+-)-3-(2-ethoxy-5-methoxy-phenyl)-1...)
Affinity DataKi:  5.5nM ΔG°:  -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175063(US9688678, 24 (+)-1-(2,4-dimethoxyphenyl)sulfonyl-...)
Affinity DataKi:  55nM ΔG°:  -41.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM174968(US9688678, 1B (−)-3-(2-ethoxy-5-methoxy-phen...)
Affinity DataKi:  55nM ΔG°:  -41.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM174969(US9688678, 2 (+-)-1-(2,4-dimethoxyphenyl)sulfonyl-...)
Affinity DataKi:  55nM ΔG°:  -41.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM174970(US9688678, 3 (+-)-3-(2-ethoxy-5-methoxy-phenyl)-3-...)
Affinity DataKi:  55nM ΔG°:  -41.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175032(US9688678, 5 (+-)-3-(2-ethoxy-5-methoxy-phenyl)-1-...)
Affinity DataKi:  55nM ΔG°:  -41.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175053(US9688678, 16 (+-)-3-(2-ethoxy-5-methoxy-phenyl)-1...)
Affinity DataKi:  55nM ΔG°:  -41.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175052(US9688678, 15 (+-)-3-(2-ethoxy-5-methoxy-phenyl)-3...)
Affinity DataKi:  55nM ΔG°:  -41.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175048(US9688678, 14 (+-)-1-(4-cyanophenyl)sulfonyl-3-(2-...)
Affinity DataKi:  55nM ΔG°:  -41.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175040(US9688678, 12 (+-)-3-(2-ethoxy-3-pyridyl)-1-(4-met...)
Affinity DataKi:  55nM ΔG°:  -41.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM175210(US9688678, 32 (3S)-3-(2-ethoxy-5-methoxy-phenyl)-1...)
Affinity DataKi:  55nM ΔG°:  -41.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM260199(US9522914, A-01)
Affinity DataIC50:  15nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM260200(US9522914, A-02)
Affinity DataIC50:  3.70nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM260201(US9522914, A-03)
Affinity DataIC50:  55nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM260202(US9522914, A-04)
Affinity DataIC50:  55nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM260203(US9522914, A-05)
Affinity DataIC50:  55nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM260204(US9522914, A-06)
Affinity DataIC50:  55nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM260205(US9522914, A-07)
Affinity DataIC50:  18nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM260206(US9522914, A-08)
Affinity DataIC50:  0.820nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM260207(US9522914, A-09)
Affinity DataIC50:  16nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM260208(US9522914, A-10)
Affinity DataIC50:  3.70nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM260209(US9522914, A-11)
Affinity DataIC50:  10nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM260210(US9522914, A-12)
Affinity DataIC50:  17nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM260211(US9522914, A-13)
Affinity DataIC50:  55nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 385 total ) | Next | Last >>
Jump to: